Goodwin Procter advised FibroGen, Inc. on the deal. FibroGen, Inc. announced its capped royalty monetization financing with NovaQuest Capital Management. The non-dilutive financing provides FibroGen with…
FibroGen’s Royalty Monetization Financing with NovaQuest Capital Management
